CANNIMED THERAPEUTICS INC. and AURORA CANNABIS INC., File No. 2017-74
TORONTO, Dec. 12, 2017 /CNW/ - On December 12, 2017, the Commission issued a Notice of Hearing pursuant to Sections 104 and 127 of the Securities Act, RSO 1990, c S.5 to consider the Amended Application filed by CanniMed Therapeutics Inc. ("CanniMed") dated December 11, 2017, in respect of a request for an order that the exemption created by section 2.2(3) of National Instrument 62-104 Take-Over Bids and Issuer Bids to the restrictions on purchases during a take-over bid found in section 2.2(1) of NI 62-104 shall not apply to Aurora Cannabis Inc. until (i) March 9, 2018, or (ii) if the Commission grants the relief sought in the Amended Application of the Special Committee of the Board of Directors of CanniMed, File No. 2017-73, then 105 days after the date upon which a take-over bid circular that complies with insider bid rules is delivered to CanniMed's shareholders.
The hearing will be held on December 20, 2017 at 9:00 a.m. at 20 Queen Street West, 17th Floor, Toronto, Ontario.
OFFICE OF THE SECRETARY
SECRETARY TO THE COMMISSION
SOURCE Ontario Securities Commission
For further information: For media inquiries: [email protected]; For investor inquiries: OSC Contact Centre, 416-593-8314, 1-877-785-1555 (Toll Free)